Sign Up to like & get
recommendations!
0
Published in 2020 at "Oncoimmunology"
DOI: 10.1080/2162402x.2020.1845424
Abstract: ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is one of the most common tumor subtypes and remains associated with very poor survival. T cell infiltration into tumor tissue is associated with improved clinical outcome but little is…
read more here.
Keywords:
phenotype;
tumor tissue;
tumor;
cells pancreatic ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Immunology Research"
DOI: 10.1158/2326-6066.cir-22-0121
Abstract: Immunotherapy has had little success in PDAC. The authors report an in-depth investigation of the PDAC tumor microenvironment that highlights PD-1 and TIGIT, or their corresponding ligands, as potential targets for combinatorial therapy to treat…
read more here.
Keywords:
resident memory;
tissue resident;
ductal adenocarcinoma;
pancreatic ductal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.667170
Abstract: Insulin-producing β-cells constitute the majority of the cells in the pancreatic islets. Dysfunction of these cells is a key factor in the loss of glucose regulation that characterizes type 2 diabetes. The regulation of many…
read more here.
Keywords:
vascular cells;
role vascular;
pancreatic beta;
cells pancreatic ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v29.i17.2701
Abstract: Several studies have shown that the immune system is highly regulated by tryptophan metabolism, which serves as an immunomodulatory factor. The indoleamine 2,3-dioxygenase 1 (IDO1), as an intracellular enzyme that participates in metabolism of the…
read more here.
Keywords:
metabolism;
tryptophan metabolism;
pancreatic cancer;
cancer stroma ... See more keywords